MHRA (UK) · Aug 6, 2026
MHRA approves remibrutinib for adults with chronic spontaneous urticaria
As with any medicinal product, the MHRA will keep the safety and effectiveness of remibrutinib under close review.
Global Health
UK, EU & international health agencies
UKHSA (UK) · Aug 6, 2026
Guidance: Chlamydia Testing Activity Dataset (CTAD): specification and technical guidance
Guidance and specifications for the recording and extraction of CTAD data from laboratories in England processing local authority and NHS commissioned chlamydia tests.
DHSC (UK) · Aug 6, 2026
Notice: Life Sciences Healthcare Goals
The Healthcare Goals programme brings together industry, academia, the third sector and the NHS to tackle healthcare challenges such as dementia, cancer, mental health, obesity and addiction.
MHRA (UK) · Aug 6, 2026
Belzer UW® Cold Storage Solution and Belzer MPS® (UW Machine Perfusion Solution): manufactured by Carnamedica (UKRP: Bridge to Life): Updated advice on the contamination of fluid DSI/2026/006 (update to DSI/2023/005)
The MHRA is providing an update on defects previously identified with Belzer solutions for the preservation of donated organs. This DSI replaces advice in DSI/2023/005.
DHSC (UK) · Aug 5, 2026
Major expansion of community mental health support across England
£343 million plan will open 159 NHS mental health centres in England, giving people earlier local support and specialist crisis care outside A&E.
DHSC (UK) · Aug 5, 2026
Patients with motor neurone disease set for fast-tracked care
Health and Social Care Secretary announces faster access to care and support for motor neurone disease patients during a visit to the Rob Burrow Centre.
MHRA (UK) · Aug 5, 2026
Decision: Advertising investigations: July 2026
Decisions made by MHRA on adverts reported to have breached the legislation on advertising medicines.
DHSC (UK) · Aug 5, 2026
Guidance: Child death overview panels: contacts
Contact details of the people in child death overview panels (CDOPs) who are responsible for receiving child death notifications.
DHSC (UK) · Aug 5, 2026
Medicine supply management
An overview of the systems and processes DHSC and NHS England use for responding to medicine shortages.
DHSC (UK) · Aug 5, 2026
Guidance: Ensuring the efficient supply and distribution of medicines to patients
Guidance on the roles and responsibilities of marketing authorisation holders, wholesalers and procurers in maintaining the supply of medicines and minimising the risk of shortages.
DHSC (UK) · Aug 5, 2026
Policy paper: Digital Inclusion Action Plan: One Year On
Progress report on delivering the Digital Inclusion Action Plan.
UKHSA (UK) · Aug 5, 2026
Guidance: Why is my baby being offered an RSV immunisation?
This leaflet is for parents of premature babies who are offered Clesrovimab or Nirservimab to help protect their baby against respiratory syncytial virus (RSV).
UKHSA (UK) · Aug 5, 2026
Zika virus: sample testing advice
Guidance on who to test for Zika virus infection and which samples to collect.
UKHSA (UK) · Aug 5, 2026
Cryptosporidium Reference Unit (CRU)
The national reference unit for cryptosporidium provides expert management, prevention and control advice as well as laboratory typing and confirmation services.
MHRA (UK) · Aug 5, 2026
Guidance: Innovative Licensing and Access Pathway (ILAP)
The Innovative Licensing and Access Pathway (ILAP) is focused on getting the most transformative new medicines to patients in the UK health system more quickly.
UKHSA (UK) · Aug 5, 2026
Guidance: Pneumococcal: the green book chapter
Pneumococcal immunisation information for public health professionals.
DHSC (UK) · Aug 5, 2026
Guidance: Medicine supply disruption statistics, UK: background and methodology
How the Department of Health and Social Care (DHSC) puts together the twice-yearly statistics on medicine supply disruption in the UK.
DHSC (UK) · Aug 5, 2026
Official Statistics: Medicine supply disruption statistics, UK: data to June 2026
Twice-yearly official statistics on medicine supply issue and discontinuation notifications reported to DHSC by pharmaceutical suppliers.
MHRA (UK) · Aug 4, 2026
Field Safety Notices: 27 to 31 July 2026
List of Field Safety Notices from 27 to 31 July 2026
UKHSA (UK) · Aug 4, 2026
Guidance: Tick-borne encephalitis: the green book
Tick-borne encephalitis immunisation information for public health professionals, including updates.
MHRA (UK) · Aug 4, 2026
The Innovative Licensing and Access Pathway grants Innovation Passports to investigational products for cancer and dementia
Innovative investigational products for liver cancer and dementia recognised through the Innovative Licensing and Access Pathway ahead of next application round opening.
UKHSA (UK) · Aug 3, 2026
Guidance: Pneumococcal polysaccharide conjugate vaccine (PCV20) PGD template
Patient group direction (PGD) template to support the provision of pneumococcal polysaccharide conjugate vaccine (PCV20).
UKHSA (UK) · Aug 3, 2026
Guidance: PCV (13-valent or 15-valent, adsorbed): patient group direction (PGD) template
PGD template to support the national pneumococcal polysaccharide conjugate vaccine (13-valent or 15-valent, adsorbed) (PCV) vaccination programme.
UKHSA (UK) · Aug 3, 2026
Guidance: BCG Vaccine AJV: patient group direction (PGD) template
PGD template to support the administration of BCG Vaccine AJV to individuals under 16 years of age at increased risk of tuberculosis.